3-52476525-G-A
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_007184.4(NISCH):c.844G>A(p.Val282Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000502 in 1,614,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_007184.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NISCH | NM_007184.4 | c.844G>A | p.Val282Ile | missense_variant | 8/21 | ENST00000345716.9 | NP_009115.3 | |
NISCH | NM_001276293.2 | c.844G>A | p.Val282Ile | missense_variant | 8/13 | NP_001263222.2 | ||
NISCH | NM_001276294.2 | c.844G>A | p.Val282Ile | missense_variant | 8/14 | NP_001263223.2 | ||
NISCH | XM_047447373.1 | c.844G>A | p.Val282Ile | missense_variant | 8/18 | XP_047303329.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NISCH | ENST00000345716.9 | c.844G>A | p.Val282Ile | missense_variant | 8/21 | 1 | NM_007184.4 | ENSP00000339958.4 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152124Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251458Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135904
GnomAD4 exome AF: 0.0000458 AC: 67AN: 1461806Hom.: 0 Cov.: 30 AF XY: 0.0000385 AC XY: 28AN XY: 727212
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152242Hom.: 0 Cov.: 33 AF XY: 0.0000806 AC XY: 6AN XY: 74434
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 27, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at